Collegium Pharmaceutical ...

NASDAQ: COLL · Real-Time Price · USD
37.71
0.55 (1.48%)
At close: Aug 15, 2025, 3:59 PM
37.74
0.08%
After-hours: Aug 15, 2025, 04:34 PM EDT

Collegium Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
631.45M 566.77M 463.93M 276.87M
Cost of Revenue
254.1M 240.6M 254.44M 126.25M
Gross Profit
377.34M 326.17M 209.49M 150.62M
Operating Income
169.9M 166.96M -104.57M -46.7M
Interest Income
13.98M 15.62M 1.05M 12K
Pretax Income
98.57M 75.73M -28.85M -3.37M
Net Income
69.19M 48.16M -25M 71.52M
Selling & General & Admin
210.36M 159.21M 172.19M 118.96M
Research & Development
n/a n/a 3.98M 9.45M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
210.36M 150.71M 176.17M 128.41M
Interest Expense
73.97M 83.34M 63.21M 21.01M
Selling & Marketing Expenses
n/a 7.41M 11.74M 4.19M
Cost & Expenses
464.47M 399.81M 430.61M 254.66M
Income Tax Expense
29.38M 27.58M -3.85M -74.89M
Shares Outstanding (Basic)
32.27M 33.74M 33.83M 34.94M
Shares Outstanding (Diluted)
40.42M 41.79M 33.83M 41.05M
EPS (Basic)
2.14 1.60 -0.74 2.05
EPS (Diluted)
1.86 1.29 -0.74 1.86
EBITDA
341.7M 308.33M 168.76M 86.58M
EBIT
172.54M 159.07M 34.37M 17.64M
Depreciation & Amortization
169.16M 149.26M 134.39M 68.94M